Buscar Noticias
Noticias de hoy
Airbnb Boosts IPO Price Range to Between $56 and $60 a Share
The home-rental company plans to boost the proposed price range of its initial public offering to between $56 and $60 a share, the latest sign that the red-hot IPO market is ending the year on a high note.
The Wall Street Journal | | Fuente originalCovid Shrinks the Labor Market, Pushing Out Women and Baby Boomers
Nearly four million Americans have stopped working or looking for jobs, a 2.2% contraction of the U.S. work force. A smaller labor market leaves fewer workers to build machines and clean tables, restraining the economy’s long-term prospects.
The Wall Street Journal | | Fuente originalWSJ News Exclusive | U.S. in Talks With Huawei Finance Chief Meng Wanzhou About Resolving Criminal Charges
The Justice Department is discussing an arrangement with Meng Wanzhou that would allow her to return home to China from Canada, in exchange for admitting wrongdoing in a criminal case that has strained Beijing’s relations with the U.S. and Canada.
The Wall Street Journal | | Fuente originalDyal Capital in Talks to Combine With Owl Rock Capital
The talks are part of a complicated deal with a special-purpose acquisition company that would value the fast-growing asset managers at about $13 billion combined and take them public.
The Wall Street Journal | | Fuente originalChina Has One Powerful Friend Left in the U.S.: Wall Street
A U.S.-China trade deal left many U.S. industries disappointed, but financial firms such as BlackRock see a potential windfall.
The Wall Street Journal | | Fuente originalThe Covid Pandemic Could Cut Business Travel by 36%—Permanently
Between 19% and 36% of all business trips could disappear, given efficiencies developed during the lockdown, our Middle Seat columnist and airline experts estimate.
The Wall Street Journal | | Fuente originalPfizer and BioNTech’s Covid-19 Vaccine Wins U.K. Authorization
Britain became the first Western nation to grant emergency-use authorization for a Covid-19 vaccine, clearing a shot developed by Pfizer and Germany’s BioNTech to be distributed in limited numbers within days.
The Wall Street Journal | | Fuente originalMás leídas hoy
- El empresariado alza la voz contra la inacción política frente a la crisis
- El Reino Unido desafía a la UE y altera unilateralmente el Protocolo de Irlanda
- Peidró (Also): "La mal llamada IA es un término marketiniano"
- He pagado de más a Hacienda, ¿cómo consigo que me lo devuelva?
- Las guerras eternas del feminismo: del "sólo sí es sí" a la 'Ley Trans'
- El Gobierno ampliará hasta el 31 de diciembre la moratoria para evitar que las empresas presenten concurso
- La negativa de Madrid a cerrar bloquea el plan de Sanidad y las autonomías para evitar un nuevo repunte en Semana Santa
- Electric Vehicles Are the U.S. Auto Industry’s Future—if Dealers Can Figure Out How to Sell Them
- El Gobierno se plantea transferir más dinero a las autonomías para que ayuden a las empresas
- Revolución en el IVA del comercio online
- "Están desapareciendo millones de trabajos y los hombres sufrirán más que las mujeres"
- 8-M: todos contra todos
- Moncloa suspende en la gestión de la pandemia con peor nota que las CCAA
- La vida en pareja aumenta la brecha de género
- Google’s FLoC Is a Terrible Idea
- Calviño quiere que la mayoría de los 11.000 millones sean ayudas directas